fbpx
Subscribe
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

Archive

First single-dose medicine for P. vivax malaria prequalified by WHO and included in WHO Guidelines – GSK

Written by | 8 Dec 2024

GSK plc and Medicines for Malaria Venture (MMV) announced that the World Health Organization (WHO) has awarded prequalification to tafenoquine, the first single-dose medicine for the prevention of… read more.

Mosquitoes importing malaria to Europe via air travel

Written by | 4 Nov 2024

Malaria cases resulting from bites of mosquitoes transported by aircraft from areas where the disease is common have increased, according to two new studies: a retrospective analysis in… read more.

African women living with HIV have an effective option to prevent malaria during pregnancy

Written by | 6 Feb 2024

In women living with HIV, preventive treatment with DHA-PPQ is a safe and effective strategy to prevent malaria during pregnancy, according to the final results of MAMAH, a clinical trial funded by the… read more.

Scientists find ‘concerning’ flaw in malaria diagnostics

Written by | 21 Aug 2023

Current methods can vastly overestimate the rates that malaria parasites are multiplying in an infected person’s blood, which has important implications for determining how harmful they could be… read more.

A three-dose malaria vaccine shows safety, efficacy in West African adults

Written by | 8 Jan 2023

A three-dose regimen of a whole-parasite vaccine against malaria — called Plasmodium falciparum sporozoite (PfSPZ) vaccine — demonstrated safety and efficacy when tested in adults living in Burkina… read more.

Unexpected antibody type found in people with malaria infections

Written by | 18 Nov 2021

Malaria, a pathogen transmitted into blood by mosquitoes in tropical climates, is typically thought of as a blood and liver infection. However, in a newly published study, researchers… read more.

CHMP recommends Artesunate Amivas for the initial treatment of severe malaria – Amivas

Written by | 13 Oct 2021

The Committee for Medicinal Products for Human Use (CHMP) adopted a positive opinion, recommending the granting of a marketing authorisation for the medicinal product Artesunate Amivas, intended for… read more.

Investigational malaria vaccine gives strong, lasting protection

Written by | 6 Jul 2021

Two U.S. Phase 1 clinical trials of a novel candidate malaria vaccine have found that the regimen conferred unprecedentedly high levels of durable protection when volunteers were later… read more.

Malaria vaccine becomes first to achieve WHO-specified 75% efficacy goal

Written by | 29 Apr 2021

Researchers from the University of Oxford and their partners have today reported findings from a Phase IIb trial of a candidate malaria vaccine, R21/Matrix-M, which demonstrated high-level efficacy… read more.

Malaria test as simple as a bandage

Written by | 13 Dec 2020

Testing for malaria could become as simple as putting on a bandage. That’s the idea behind a platform developed by Rice University engineers who introduced a microneedle patch… read more.

Newsletter Icon

Subscribe for our mailing list

If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.

Subscribe

You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.